Gülsüm Özet

1.3k total citations
90 papers, 746 citations indexed

About

Gülsüm Özet is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Gülsüm Özet has authored 90 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Hematology, 39 papers in Genetics and 19 papers in Oncology. Recurrent topics in Gülsüm Özet's work include Chronic Lymphocytic Leukemia Research (21 papers), Lymphoma Diagnosis and Treatment (13 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers). Gülsüm Özet is often cited by papers focused on Chronic Lymphocytic Leukemia Research (21 papers), Lymphoma Diagnosis and Treatment (13 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers). Gülsüm Özet collaborates with scholars based in Türkiye, United States and Spain. Gülsüm Özet's co-authors include Simten Dağdaş, Rauf Haznedar, Nahıde Konuk, Hürrem Bodur, Meral Beksaç, Meltem Aylı, Emın Kaya, Rıdvan Ali, Işık Kaygusuz and İsmet Aydoğdu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Gülsüm Özet

70 papers receiving 719 citations

Peers

Gülsüm Özet

HEMAT

ONCOL

GENET

PFM

Nobuhiko Uoshima Japan

Marianna Criscuolo Italy

Ignacio Lorenzo Spain

A. Grigg Australia

Adina Cioc United States

Roni Tamari United States

Ola Landgren United States

Mitsutoshi Kurosawa Japan

Matteo Luciani Italy

Nada Suvajdžić Serbia

Nobuhiko Uoshima Japan

Gülsüm Özet

336 ×0.9

HEMAT

311 ×1.3

ONCOL

172 ×0.8

153 ×1.0

GENET

178 ×1.6

PFM

Citations per year, relative to Gülsüm Özet Gülsüm Özet (= 1×) peers Nobuhiko Uoshima

Countries citing papers authored by Gülsüm Özet

Since Specialization

Citations

This map shows the geographic impact of Gülsüm Özet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gülsüm Özet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gülsüm Özet more than expected).

Fields of papers citing papers by Gülsüm Özet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gülsüm Özet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gülsüm Özet. The network helps show where Gülsüm Özet may publish in the future.

Co-authorship network of co-authors of Gülsüm Özet

This figure shows the co-authorship network connecting the top 25 collaborators of Gülsüm Özet. A scholar is included among the top collaborators of Gülsüm Özet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gülsüm Özet. Gülsüm Özet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Özet, Gülsüm, et al.. (2025). Eosin-5′-maleimide (EMA)-binding assay as a diagnostic method of hereditary spherocytosis. Turkish Journal of Biochemistry. 50(5). 668–675.

Sevindik, Ömür Gökmen, Simten Dağdaş, Leylagül Kaynar, et al.. (2024). Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience. Leukemia Research. 140. 107484–107484. 2 indexed citations

Dağdaş, Simten, et al.. (2024). ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) PRESENTING AS STEVENS-JOHNSON SYNDROME (SJS). Hematology Transfusion and Cell Therapy. 46. S32–S33.

Namdaroğlu, Sinem, Mehmet Ali Erkurt, İlhami Berber, et al.. (2024). The role of ruxolitinib in the management of acute GVHD. Transfusion and Apheresis Science. 64(1). 104055–104055.

Dağdaş, Simten, et al.. (2024). Effectiveness and safety of therapeutic plasma exchange in neurological diseases: An 11‐year report from a tertiary care center. Therapeutic Apheresis and Dialysis. 29(2). 312–320. 1 indexed citations

Güner, Rahmet, et al.. (2024). Investigation of polypharmacy, antimicrobial-related potential drug–drug interactions in patients with hematological malignancies. Journal of Oncology Pharmacy Practice. 31(4). 587–596.

Dağdaş, Simten, et al.. (2021). A novel differential diagnosis algorithm for chronic lymphocytic leukemia using immunophenotyping with flow cytometry. Hematology Transfusion and Cell Therapy. 45(2). 176–181. 6 indexed citations

Dal, Mehmet Sinan, Olga Meltem Akay, Özgür Mehtap, et al.. (2021). Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients. Journal of Chemotherapy. 34(3). 190–198. 8 indexed citations

Özet, Gülsüm, et al.. (2021). Determination of reference ranges for automated erythrocyte and reticulocyte parameters in healthy adults. SHILAP Revista de lepidopterología. 47(3). 283–287. 1 indexed citations

10.

Kaplan, Mustafa, Nisbet Yılmaz, & Gülsüm Özet. (2018). Evaluation of basal immature reticulocyte fraction (IRF) level and IRF response to iron therapy in patients with newly diagnosed iron deficiency anemia. AYBU AVESIS. 10(4). 431–435. 1 indexed citations

11.

Koçoğlu, Hakan, Deniz Tural, Yıldız Okuturlar, et al.. (2018). Hepatitis B and C rates are significantly increased in certain solid tumors: A large retrospective study. Journal of Cancer Research and Therapeutics. 14(10). 774–774. 13 indexed citations

12.

Büyükaşık, Yahya, İbrahim C. Haznedaroğlu, Gülsüm Özet, et al.. (2017). The Modelled Effectiveness of Ruxolitinib on Survival in Polycythemia Patients with Hydroxyurea Resistance/Intolerance in Turkey. Value in Health. 20(9). A545–A545. 1 indexed citations

13.

Özet, Gülsüm, et al.. (2016). Dissemine İntravasküler Koagülasyon (Yaygın Damar içi Pıhtılaşma). 9(3). 146–150. 1 indexed citations

14.

Ateş, İhsan, et al.. (2016). Combined factor V and VIII deficiency in a young woman with abundant bleeding after tooth extraction. Blood Research. 51(1). 67–67. 1 indexed citations

15.

Tuna, Mazhar Müslüm, Narin Nasıroğlu İmga, Berçem Ayçıçek Doğan, et al.. (2015). Acute Monocytic Leukemia with Pituitary Involvement: A Case Report. SHILAP Revista de lepidopterología. 19(2). 69–71.

16.

Albayrak, Murat, et al.. (2010). Evaluation of risk factors for thrombophilia in patients with cerebral venous thrombosis. Turkish Journal of Hematology. 27(3). 162–167. 3 indexed citations

17.

Albayrak, Murat, et al.. (2010). Thrombophilic risk factors in women with recurrent abortion. SHILAP Revista de lepidopterología. 1(3). 4 indexed citations

18.

Demirer, Taner, Meltem Aylı, Yavuz Selim Genç, et al.. (2003). High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation. Bone Marrow Transplantation. 31(9). 755–761. 5 indexed citations

19.

Demirer, Taner, Meltem Aylı, Rauf Haznedar, et al.. (2002). Influence of post‐transplant recombinant human granulocyte colony‐stimulating factor administration on peritransplant morbidity in patients undergoing autologous stem cell transplantation. British Journal of Haematology. 118(4). 1104–1111. 18 indexed citations

20.

Baysallar, Mehmet, et al.. (1996). Parvovirus B19 antibodies in diseases associated with vasculitis. 14(1). 10–12. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact